Advanced search
Publication Cover
International Journal of Cardiovascular Interventions Volume 2, 1999 - Issue 2
Journal homepage
9
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The effects of L-arginine on atherosclerosis and heart disease

Arnon Blum Cardiology Branch, NHLBI, Building 10, Room 7B15, Bethesda, MD, 20892, USA
,
Hylton Miller Cardiology Branch, NHLBI, Building 10, Room 7B15, Bethesda, MD, 20892, USA
,
Arnon Blum Cardiology Department, Tel-Aviv Medical Center, Israel
&
Hylton Miller Cardiology Department, Tel-Aviv Medical Center, Israel
Pages 97-100 | Published online: 10 Jul 2009

  • Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
  • Lefer AM, Ma XI. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb 1993; 13: 771-776.
  • Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988; 63: 903-910.
  • Cushing SD, Berliner JA, Valente AJ, et al. Minimally oxidized low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990; 87: 5134-5138.
  • Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. I Am Coll Cardiol 1994; 24: 1591-1601.
  • Graber N, Gopal TV, Wilson D, Beall LD, Polte T, Newman W. T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J Immunol 1990; 145: 819-830.
  • Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
  • Carlos TM, Schwartz BR, Kovach NL, et al. Vascular adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured endothelial cells. Blood 1990; 76: 965-970.
  • Kim JA, Wayner TE, Parhami CF, et al. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb 1994; 14: 427-433.
  • Takahashi M, Ikeda U, Masuyama J-I, et al. Involvement of adhesion molecules in human monocyte adhesion to and transmigration through endothelial cells in vitro. Atherosclerosis 1994; 108: 73-81.
  • Luscinskas FW, Kansas GS, Ding H, et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1 integrins and beta 2 integrins. J Cell Biol 1994; 125: 1417-1427.
  • Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
  • Stamler JS, Loh E, Roddy MA, Curie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89: 2035-2040.
  • Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
  • Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-1172.
  • Boger RH, Bode-Boger SM, Mugge A, et al. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995; 117: 273-284.
  • Tsao PS, Theilmeier G, Singer AH, Leung LK, Cooke JP. L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 1529-1533.
  • Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke IP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994; 89: 2176-2182.
  • Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992; 90: 1248-1253.
  • Clarkson P, Adams MR, Powe AJ, et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults (Abstr). Circulation 1995; 92(suppl I): I-366.
  • Adams MR, Forsyth CJ, Jessup W, Robinson J, Celemajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young adults. I Am Coll Cardiol 1995; 26: 1054-1061.
  • Adams MR, Jessup W, Hailstones D, Celemajer D. L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 1997; 95: 662-668.
  • Palmar RMJ, Ashton DJ, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
  • Wang BY, Candipan RC, Arjomandi M, Hsium PTC, Tsao PS, Cooke PJ. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1996; 28: 1573-1579.
  • Tsao P, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994; 89: 2176-2182.
  • Peng HB, Libby P, Liao JK. Induction and stabilization of I 3B alpha by nitric oxide mediates inhibition of NF 3B. J Biol Chem 1995; 270: 14214-14219.
  • Barnes PJ, Karin M. Nuclear factor kappa B--a pivotal transcriptional factor in chronic inflammatory diseases. N Engl J Med 1997; 336(15): 1066-1071.
  • Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-589.
  • De caterina R, Libby P, Peng HB, Thannickal VJ, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
  • Peng HB, Rajarashisth TB, Libby P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1991; 40: 794-799.
  • Zeiher AH, Fisslhalter B, Schray Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemotactic protein 1 in cultured human endothelial cells. Circ Res 1995; 76: 980-986.
  • Newman W, Beall LD, Carson CW, et al. Soluble e-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150(2): 644-654.
  • Spertini O, Schleiffenbaum B, White-Owin C, Ruiz P, Tedder T. ELISA for quantitation of L-selectin shed from leukocytes in vivo. J Immun Methods 1992; 156: 115-123.
  • Schleiffenbaum B, Olivier S, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992; 119: 229-238.
  • Rothlein R, Mainolfi EA, Czajkowski M. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.
  • Nakai K, Itoh C, Kawazoe K, et al. Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression pfVCAM-1 mRNA in the human atherosclerotic aorta. Coronary Art Dis 1995; 6: 497-502.
  • Haught WH, Mansour M, Rothlein R, et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: Further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996; 132: 1-8.
  • Peter K, Nawroth P, Couradt C, et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule 1, E-selectin, P-selectin, and thrombo-modulin. Arterioscler Thromn Vasc Biol 1997; 17: 505-512.
  • Mazzone A, De Servi S, Ricevuti G, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363.
  • Cooke J, Singer A, Tsao P, Zera P, Rowan R, Billingham M. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-1172.
  • Boger R, Bode-Boger S, Mugge A. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995; 117: 273-284.
  • Tsao P, McEvoy L, Drexler H, Butcher E, Cooke J. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994; 89: 2178-2182.
  • Candipan R, Wang B, Buitrago R, Tsao P, Cooke J. Regression or progression: dependency on vascular nitric oxide. Arteriolar Thromb Vasc Biol 1996; 16: 44-50.
  • Davies M, Dalen H, Koi J, Barber L, Svendsen E, Hagen P. Control of accelerated vein graft atheroma with the nitric oxide precursor L-arginine. J Surg Res 1995; 59: 35-42.
  • Aji A, Ravalli S, Szabolcs M. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 1997; 95: 430-437.
  • Drexler H, Zeiher A, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patient by L-arginine. Lancet 1991; 338: 1546-1550.
  • Adams RM, Forsyth CJ, Jessup W, Robinson J, Celemajer DS.Oral L-arginine inhibits but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol 1995; 26: 1054-1061.
  • Clarkson P, Adams MR, Powe AJ, et al. Oral L-arginine improves endothelium dependent dilation in hypercholesterolemic young adults. J Clin Invest 1996; 97: 1989-1994.
  • Rector TS, Bank AJ, Kathleen AM, et al. Randomized double-blind, placebo controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996; 93: 2135-2141.
  • Chin-Dusting PF, Kaye DM, Lefkovits J, Wong J, Bergin P, Jennings GL. Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol 1996; 27: 1207-1213.
  • Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol 1997; 29: 491-497.
  • Bode-Boger SM, Boger RH, Kienke S, Junker W, Frolich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996; 219: 598-603.
  • Cooke JP, Tsao PS. Arginine: a new therapy for atherosclerosis? Circulation 1997; 95: 311-312.
  • Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.
  • Loscalzo J. The induction of cellular interactions in atherogenesis and their modulation. Biochem Soc Trans 1993; 21: 656-659.
  • Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-512.
  • Bevilacqua M, Nelson RM. Selectins. J Clin Invest 1993; 91: 379-387.
  • Carlos TM, Harlan JM. Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 1990; 114: 5-28.
  • Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 1997; 129: 261-269.
  • Wolf A, Zalpour C, Theilmeier G, et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 1997; 29: 479-485.
  • Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilatation in healthy young men. J Am Coll Cardiol 1995; 26: 1054-1061.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.